EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

A Retrospective Cohort Study Evaluating the Safety and Efficacy of Sequential versus Concurrent Intrapleural Instillation of Tissue Plasminogen Activator and DNase for Pleural Infection

Ken Junyang Goh iD, Wui Mei Chew, Jasmine Chiat Ling Ong, Carrie Kah-Lai Leong, Imran Bin Mohamed Noor, Devanand Anantham, Li Yan Sandra Hui, Mindy Chu Ming Choong, Charlene Jin Yee Liew, Marnie Tamayo Gutierrez, Jane Jing Yi Wong, Ivana Gilcrist Chiew Sian Phua und 2 weitere

Pulmonary Medicine · 2023

DOI: 10.1155/2023/6340851 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Pulmonary Medicine, 2023. Verfasst von Ken Junyang Goh und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore. Hauptthemen laut MEDLINE: Pleural Diseases, Tissue Plasminogen Activator, Deoxyribonucleases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective. Intrapleural tissue plasminogen activator/deoxyribonuclease (tPA/DNase) is increasingly being used for pleural infections. Compared to sequential instillation of tPA/DNase, concurrent instillation considerably reduces the complexity of the administration process and reduces workload and the number of times the chest drain is accessed. However, it remains unclear if concurrent intrapleural therapy is as efficacious or safe as sequential intrapleural therapy.

Methods

We conducted a retrospective review of patients with pleural infection requiring intrapleural therapy at two tertiary referral centres.

Results

We included 84 (62.2%) and 51 (37.8%) patients who received sequential and concurrent intrapleural therapy, respectively. Patient demographics and clinical characteristics, including age, RAPID score, and percentage of pleural opacity on radiographs before intrapleural therapy, were similar in both groups. Treatment failure rates (defined by either in-hospital mortality, surgical intervention, or 30-day readmission for pleural infection) were 9.5% and 5.9% with sequential and concurrent intrapleural therapy, respectively ( p = 0.534 ). This translates to a treatment success rate of 90.5% and 94.1% for sequential and concurrent intrapleural therapy, respectively. There was no significant difference in the decrease in percentage of pleural effusion size on chest radiographs (15.1% [IQR 6-35.7] versus 26.6% [IQR 9.9-38.7], p = 0.143 ) between sequential and concurrent therapy, respectively. There were also no significant differences in the rate of pleural bleeding (4.8% versus 9.8%, p = 0.298 ) and chest pain (13.1% versus 9.8%, p = 0.566 ) between sequential and concurrent therapy, respectively.

Conclusion

Our study adds to the growing literature on the safety and efficacy of concurrent intrapleural therapy in pleural infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pleural DiseasesTissue Plasminogen ActivatorDeoxyribonucleasesRetrospective StudiesCohort StudiesHumansMaleFemaleMiddle AgedAgedTreatment OutcomeFibrinolytic AgentsPleural Effusion

Substanzen

Tissue Plasminogen ActivatorDeoxyribonucleasesFibrinolytic Agents

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore.
  • Department of Respiratory and Critical Care Medicine, Changi General Hospital, Singapore.
  • Division of Pharmacy, Singapore General Hospital, Singapore.
  • Department of Diagnostic Radiology, Singapore General Hospital, Singapore.
  • Department of Diagnostic Radiology, Changi General Hospital, Singapore.
  • Advanced Practice Nurse Development, Changi General Hospital, Singapore.

ORCID-Profile: Ken Junyang Goh

Zitieren

APA

Goh, K. J., Chew, W. M., Ong, J. C. L., Leong, C. K., Mohamed Noor, I. B., Anantham, D., Hui, L. Y. S., Choong, M. C. M., Liew, C. J. Y., Gutierrez, M. T., Wong, J. J. Y., Phua, I. G. C. S., Lim, W. T., & Tan, Q. L. (2023). A Retrospective Cohort Study Evaluating the Safety and Efficacy of Sequential versus Concurrent Intrapleural Instillation of Tissue Plasminogen Activator and DNase for Pleural Infection. Pulmonary Medicine. https://doi.org/10.1155/2023/6340851

Vancouver

Goh KJ, Chew WM, Ong JCL, Leong CK, Mohamed Noor IB, Anantham D, et al. A Retrospective Cohort Study Evaluating the Safety and Efficacy of Sequential versus Concurrent Intrapleural Instillation of Tissue Plasminogen Activator and DNase for Pleural Infection. Pulmonary Medicine. 2023. doi:10.1155/2023/6340851

BibTeX
@article{Goh2023,
  author = {Goh, Ken Junyang and Chew, Wui Mei and Ong, Jasmine Chiat Ling and Leong, Carrie Kah-Lai and Mohamed Noor, Imran Bin and Anantham, Devanand and Hui, Li Yan Sandra and Choong, Mindy Chu Ming and Liew, Charlene Jin Yee and Gutierrez, Marnie Tamayo and Wong, Jane Jing Yi and Phua, Ivana Gilcrist Chiew Sian and Lim, Wen Ting and Tan, Qiao Li},
  title = {A Retrospective Cohort Study Evaluating the Safety and Efficacy of Sequential versus Concurrent Intrapleural Instillation of Tissue Plasminogen Activator and DNase for Pleural Infection},
  journal = {Pulmonary Medicine},
  year = {2023},
  doi = {10.1155/2023/6340851}
}
Kostenlos starten →